SCHEMBL6002827

SCHEMBL6002827

[O]CC1(Cc2ccccc2)N=NN=N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
CASP1 P29466 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
KEAP1 Q14145 1/20 0.34
ELANE P08246 2/20 0.34
TDP1 Q9NUW8 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP2A6 P11509 1/20 0.33
HTR2A P28223 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
LOXL2 Q9Y4K0 1/20 0.33
KCNH2 Q12809 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5282506 0.87 MAOB (0.43) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL6002831 0.79 TSHR (0.41) ALDH1A1HPGDMAOAMAOBTDP1
SCHEMBL10967375 0.79 MAOA (0.38) ALDH1A1MAOAMAOBLOXL2CALM1
SCHEMBL5280214 0.79 TP53 (0.41) ALDH1A1MAOAMAOBELANENPSR1
SCHEMBL5275325 0.76 MMP2 (0.38) ALDH1A1HPGDHSD17B10MAOAMAOB
SCHEMBL5279760 0.75 SLC6A2 (0.35) HPGDMAOAMAOBELANETAAR1
SCHEMBL5278439 0.75 TAAR1 (0.35) ALDH1A1MAOAMAOBELANECYP2A6
SCHEMBL5284942 0.74 MAOA (0.40) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL5282068 0.72 MMP2 (0.49) ALOX12SMN1; SMN2KCNH2HTTMAPK1
SCHEMBL5274739 0.71 MMP2 (0.51) ALOX12SMN1; SMN2KCNH2HTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed